Cargando…
Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces
BACKGROUND: The current health care reform in China launched in 2009 tackles the problem of access to appropriate medicines for its 1.3 billion people by focusing on providing essential medicines to all. To provide evidence for the reform process, we investigated the manufacturing, purchasing, and p...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915989/ https://www.ncbi.nlm.nih.gov/pubmed/20637116 http://dx.doi.org/10.1186/1472-6963-10-211 |
_version_ | 1782184984948244480 |
---|---|
author | Chen, Wen Tang, Shenglan Sun, Jing Ross-Degnan, Dennis Wagner, Anita K |
author_facet | Chen, Wen Tang, Shenglan Sun, Jing Ross-Degnan, Dennis Wagner, Anita K |
author_sort | Chen, Wen |
collection | PubMed |
description | BACKGROUND: The current health care reform in China launched in 2009 tackles the problem of access to appropriate medicines for its 1.3 billion people by focusing on providing essential medicines to all. To provide evidence for the reform process, we investigated the manufacturing, purchasing, and prescribing of essential medicines in two provinces. METHODS: We conducted surveys in 2007 of all manufacturers (n = 253) and of 59 purposively selected retail and 63 hospital pharmacies in Shandong and Gansu provinces to assess production and supply of products on the 2004 National Essential Medicines List (NEML), as well as factors underlying decision making about production and supply. We also reviewed prescriptions (n = 5456) in health facilities to calculate standard indicators of appropriate medicines use. RESULTS: Overall, manufacturers in Shandong and Gansu produced only 62% and 50%, respectively, of the essential medicines they were licensed to produce. Of a randomly selected 10% of NEML products, retail pharmacies stocked up to 60% of Western products. Median availability in hospital pharmacies ranged from 19% to 69%. Manufacturer and retail pharmacy managers based decisions on medicines production and stocking on economic considerations, while hospital pharmacy managers cited clinical need. Between 64% and 86% of prescriptions contained an essential medicine. However, overprescribing of antibiotics (34%-77% of prescriptions) and injectables (22%-61%) for adult non-infectious outpatient consultations was common. CONCLUSIONS: We found that manufacturers, retail pharmacies, and hospital pharmacies paid limited attention to China's 2004 NEML in their decisions to manufacture, purchase, and stock essential medicines. We also found that prescribing of essential medicines was frequently inappropriate. These results should inform strategies to improve affordable access to essential medicines under the current health care reform. |
format | Text |
id | pubmed-2915989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29159892010-08-05 Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces Chen, Wen Tang, Shenglan Sun, Jing Ross-Degnan, Dennis Wagner, Anita K BMC Health Serv Res Research Article BACKGROUND: The current health care reform in China launched in 2009 tackles the problem of access to appropriate medicines for its 1.3 billion people by focusing on providing essential medicines to all. To provide evidence for the reform process, we investigated the manufacturing, purchasing, and prescribing of essential medicines in two provinces. METHODS: We conducted surveys in 2007 of all manufacturers (n = 253) and of 59 purposively selected retail and 63 hospital pharmacies in Shandong and Gansu provinces to assess production and supply of products on the 2004 National Essential Medicines List (NEML), as well as factors underlying decision making about production and supply. We also reviewed prescriptions (n = 5456) in health facilities to calculate standard indicators of appropriate medicines use. RESULTS: Overall, manufacturers in Shandong and Gansu produced only 62% and 50%, respectively, of the essential medicines they were licensed to produce. Of a randomly selected 10% of NEML products, retail pharmacies stocked up to 60% of Western products. Median availability in hospital pharmacies ranged from 19% to 69%. Manufacturer and retail pharmacy managers based decisions on medicines production and stocking on economic considerations, while hospital pharmacy managers cited clinical need. Between 64% and 86% of prescriptions contained an essential medicine. However, overprescribing of antibiotics (34%-77% of prescriptions) and injectables (22%-61%) for adult non-infectious outpatient consultations was common. CONCLUSIONS: We found that manufacturers, retail pharmacies, and hospital pharmacies paid limited attention to China's 2004 NEML in their decisions to manufacture, purchase, and stock essential medicines. We also found that prescribing of essential medicines was frequently inappropriate. These results should inform strategies to improve affordable access to essential medicines under the current health care reform. BioMed Central 2010-07-17 /pmc/articles/PMC2915989/ /pubmed/20637116 http://dx.doi.org/10.1186/1472-6963-10-211 Text en Copyright ©2010 Chen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Chen, Wen Tang, Shenglan Sun, Jing Ross-Degnan, Dennis Wagner, Anita K Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces |
title | Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces |
title_full | Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces |
title_fullStr | Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces |
title_full_unstemmed | Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces |
title_short | Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces |
title_sort | availability and use of essential medicines in china: manufacturing, supply, and prescribing in shandong and gansu provinces |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915989/ https://www.ncbi.nlm.nih.gov/pubmed/20637116 http://dx.doi.org/10.1186/1472-6963-10-211 |
work_keys_str_mv | AT chenwen availabilityanduseofessentialmedicinesinchinamanufacturingsupplyandprescribinginshandongandgansuprovinces AT tangshenglan availabilityanduseofessentialmedicinesinchinamanufacturingsupplyandprescribinginshandongandgansuprovinces AT sunjing availabilityanduseofessentialmedicinesinchinamanufacturingsupplyandprescribinginshandongandgansuprovinces AT rossdegnandennis availabilityanduseofessentialmedicinesinchinamanufacturingsupplyandprescribinginshandongandgansuprovinces AT wagneranitak availabilityanduseofessentialmedicinesinchinamanufacturingsupplyandprescribinginshandongandgansuprovinces |